Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GERMAIN: VMP ± lenalidomide maintenance in transplant-ineligible multiple myeloma
2012-003023-38Phase 2Terminated
- Sponsor
- Friedrich Schiller University Jena
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in multiple myeloma (MM) comparing VMP induction → lenalidomide maintenance with VMP induction → placebo maintenance (2 arms). Primary endpoint: Median progression-free survival. Started Oct 2013; status: terminated.
02
Drugs
lenalidomide
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on 2012-003023-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003023-38.